Approval · Notice of Compliance 7703 · 2006
TRINIPATCH: Notice of Compliance 7703
Issued January 26, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7703
- Date
- January 26, 2006
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antianginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRINIPATCH | 02230732 | Marketed |
| TRINIPATCH | 02230733 | Marketed |
| TRINIPATCH | 02230734 | Marketed |
Medicinal ingredients
- NITROGLYCERIN 22.4 MG per PATCH
- NITROGLYCERIN 44.8 MG per PATCH
- NITROGLYCERIN 67.2 MG per PATCH